ATE204083T1 - Herpes simplex viren diagnostik - Google Patents

Herpes simplex viren diagnostik

Info

Publication number
ATE204083T1
ATE204083T1 AT96921704T AT96921704T ATE204083T1 AT E204083 T1 ATE204083 T1 AT E204083T1 AT 96921704 T AT96921704 T AT 96921704T AT 96921704 T AT96921704 T AT 96921704T AT E204083 T1 ATE204083 T1 AT E204083T1
Authority
AT
Austria
Prior art keywords
herpes simplex
simplex virus
hsv
methods
infection
Prior art date
Application number
AT96921704T
Other languages
English (en)
Inventor
Rae Lyn Burke
D Anna Alexander
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE204083T1 publication Critical patent/ATE204083T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Luminescent Compositions (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Valve-Gear Or Valve Arrangements (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT96921704T 1995-07-28 1996-06-20 Herpes simplex viren diagnostik ATE204083T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50859895A 1995-07-28 1995-07-28
US08/613,235 US5965354A (en) 1995-07-28 1996-03-08 Herpes simplex virus diagnostics
PCT/US1996/010615 WO1997005488A1 (en) 1995-07-28 1996-06-20 Herpes simplex virus diagnostics

Publications (1)

Publication Number Publication Date
ATE204083T1 true ATE204083T1 (de) 2001-08-15

Family

ID=27056239

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96921704T ATE204083T1 (de) 1995-07-28 1996-06-20 Herpes simplex viren diagnostik

Country Status (11)

Country Link
US (1) US5965354A (de)
EP (1) EP0842430B1 (de)
JP (1) JPH11510893A (de)
AT (1) ATE204083T1 (de)
AU (1) AU6284996A (de)
CA (1) CA2227844A1 (de)
DE (1) DE69614393T2 (de)
ES (1) ES2159032T3 (de)
GR (1) GR3037090T3 (de)
PT (1) PT842430E (de)
WO (1) WO1997005488A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384640B1 (en) * 1999-09-30 2008-06-10 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant
JP2004511808A (ja) * 2000-10-17 2004-04-15 ベッスト−テスト　アンパーツゼルスカブ 体液サンプル中の生物学的細胞の直接的検出のためのアッセイ
EP1404368B1 (de) 2001-06-07 2009-12-09 Wyeth Holdings Corporation Mutantenformen von cholera holotoxin als adjuvans
AU2002322380B2 (en) * 2001-06-07 2006-11-02 Government Of The United States Of America As Represented By The Uniformed Services University Of The Health Sciences Mutant forms of cholera holotoxin as an adjuvant
WO2004043238A2 (en) * 2002-11-14 2004-05-27 Ciphergen Biosystems, Inc. Biomarkers for intra-amniotic inflammation
CN1798851B (zh) * 2003-04-25 2010-04-28 贝克顿·迪金森公司 通过核酸扩增检测1型和2型单纯疱珍病毒
US7763460B2 (en) 2005-06-24 2010-07-27 Focus Diagnostics, Inc. Methods and compositions for detecting herpes simplex virus type 2
DE112008000888T5 (de) * 2007-04-04 2011-05-19 Hugh Birchwood McTavish Nichtspezifische verzögerte Überempfindlichkeitsreaktion zur Behandlung von Herpes-Simplex-Virusinfektionen
US10107813B2 (en) 2013-12-18 2018-10-23 Board Of Trustees, Southern Illinois University Rapid and sensitive serological assay to determine if patients are infected with herpes simplex virus type 1 HSV-1 and/or type 2 HSV-2
KR102533463B1 (ko) 2015-02-26 2023-05-16 스퀘어렉스 파마슈티컬 코포레이션 단순 포진 바이러스 감염을 치료하기 위한 비특이적 지연형 과민성 반응
LT3411388T (lt) * 2016-02-01 2022-01-10 Simplexia Ab Sutrumpintas herpes simplex viruso 2 glikoproteinas g
CA3100712A1 (en) * 2018-05-17 2019-11-21 Immunome, Inc. Ch3 domain epitope tags
EP4413020A4 (de) * 2021-10-05 2025-12-17 Viro Res Llc Lateralflusstest auf herpes-simplex-virus typ 1 und 2

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149660A (en) * 1982-02-18 1992-09-22 University Patents, Inc. Diagnostic reagents relating to herpes simplex virus
US5244792A (en) * 1984-04-06 1993-09-14 Chiron Corporation Expression of recombinant glyoprotein B from herpes simplex virus
US6100064A (en) * 1984-04-06 2000-08-08 Chiron Corporation Secreted viral proteins useful for vaccines and diagnostics
US4764459A (en) * 1984-12-28 1988-08-16 The United States Of America As Represented By The Department Of Health And Human Services Enzyme-linked immunosorbent assay (ELISA) for determining anti-bodies against herpes simplex virus (HSV) types 1 and 2 in human sera
WO1990013652A1 (en) * 1989-05-12 1990-11-15 Triton Diagnostics, Inc. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
EP0527200A1 (de) * 1990-05-04 1993-02-17 E.I. Du Pont De Nemours And Company Ein verfahren zur bestimmung typspezifischer antikörpern gegen herpes-simplex-virus typen 1 und 2
JP3005292B2 (ja) * 1990-08-02 2000-01-31 カイロン コーポレイション 単純ヘルペスウィルスのｖｐ１６のワクチン

Also Published As

Publication number Publication date
EP0842430B1 (de) 2001-08-08
JPH11510893A (ja) 1999-09-21
WO1997005488A1 (en) 1997-02-13
DE69614393T2 (de) 2001-11-22
EP0842430A1 (de) 1998-05-20
DE69614393D1 (de) 2001-09-20
PT842430E (pt) 2001-11-30
CA2227844A1 (en) 1997-02-13
GR3037090T3 (en) 2002-01-31
ES2159032T3 (es) 2001-09-16
US5965354A (en) 1999-10-12
AU6284996A (en) 1997-02-26

Similar Documents

Publication Publication Date Title
DE69614393D1 (de) Herpes simplex viren diagnostik
Grangeot-Keros et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women
CA2075183A1 (en) Specimen test slide and method of testing for fecal occult blood
Schmid et al. Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2
DE3485653D1 (de) Verfahren und vorrichtung zur messung des reaktionsgrades zwischen antigenen und zell-leukozytenantikoerpern.
WO2004048600A3 (en) Diagnostic tests and methods for diagnosing inflammatory bowel disease
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
DK0946874T3 (da) Diagnose af Helicobacter Pylori
DE69819643T2 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
Dalessio et al. Highly sensitive enhanced chemiluminescence immunodetection method for herpes simplex virus type 2 Western immunoblot
CA2048655A1 (en) Discrimination between antibodies against htlv-1, htlv-ii or related retroviruses, new peptides, detection of antibodies and immunoassay kits
Van Wagoner et al. Herpes diagnostic tests and their use
Safrin et al. Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS
CN216900577U (zh) 一种用于多病原体的IgM和IgG共检测的免疫层析试剂盒
Ashley et al. Cervical antibodies in patients with oral herpes simplex virus type 1 (HSV-1) infection: local anamnestic responses after genital HSV-2 infection
Decoster et al. Detection of anti-Toxoplasma immunoglobulin A antibodies by Platelia-Toxo IgA directed against P30 and by IMx Toxo IgA for diagnosis of acquired and congenital toxoplasmosis
CN114280298A (zh) 一种用于多病原体的IgM和IgG共检测的免疫层析试剂盒
CA2174212A1 (en) Assay to detect hcv receptor binding
Shekarchi et al. Comparison of enzyme-linked immunosorbent assay with enzyme-linked fluorescence assay with automated readers for detection of rubella virus antibody and herpes simplex virus
Johnson et al. Evaluation of five commercially available immunodiffusion kits for detection of Coccidioides immitis and Histoplasma capsulatum antibodies
ES2094124T3 (es) Ensayo-inmunologico de anticuerpos contra hiv.
Gutiérrez et al. Behaviour of IgG antibody avidity for the antigen and of IgA antibody in active cytomegalovirus, Epstein-Barr virus, herpes simplex virus and human herpes virus 6 infections. Adaptation of a commercial test
Kiefer et al. Normalized enzyme-linked immunosorbent assay for determining immunoglobulin G antibodies to cytomegalovirus
CN216581644U (zh) 一种用于诊断中性粒细胞明胶酶相关脂质运载蛋白的试剂盒
EP0321249A3 (de) Mittel und Verfahren zur Diagnose von Varicella zoster-Virusinfektion

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee